These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 6189392

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A case/control study of hepatitis B virus serologic markers in Senegalese patients suffering from primary hepatocellular carcinoma.
    Coursaget P, Maupas P, Goudeau A, Chiron JP, Raynaud B, Drucker J, Barin F, Denis F, Diop Mar I, Diop B.
    Prog Med Virol; 1981; 27():49-59. PubMed ID: 6262871
    [No Abstract] [Full Text] [Related]

  • 23. High prevalence of infection with hepatitis B and C viruses in patients with hepatocellular carcinoma in Japan.
    Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Tsukamoto T, Hamba H, Shuto T, Okuda T, Tamori A, Kuroki T, Kinoshita H.
    Hepatogastroenterology; 1999; 46(25):357-9. PubMed ID: 10228821
    [Abstract] [Full Text] [Related]

  • 24. Mutation "hot spot" in HLA class I-restricted T cell epitope on hepatitis B surface antigen in chronic carriers and hepatocellular carcinoma.
    Chen WN, Oon CJ.
    Biochem Biophys Res Commun; 1999 Sep 07; 262(3):757-61. PubMed ID: 10471398
    [Abstract] [Full Text] [Related]

  • 25. Anti-tumor effects of immunotherapeutic peptide on the treatment of hepatocellular carcinoma with HBc carrier.
    Kong J, Diao Z, Deng X, Zhong H, Yao W, Hu X.
    Oncol Rep; 2007 Jul 07; 18(1):279-85. PubMed ID: 17549380
    [Abstract] [Full Text] [Related]

  • 26. Hepatitis B surface antigenemia in patients with hepatocellular carcinoma in relation to clinical course and alpha-fetoprotein.
    Kubo Y, Okuda K, Shimokawa Y, Arishima T, Nagata E.
    Gastroenterology; 1977 Jun 07; 72(6):1213-6. PubMed ID: 67061
    [Abstract] [Full Text] [Related]

  • 27. Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA.
    Shouval D, Reid LM, Chakraborty PR, Ruiz-Opazo N, Morecki R, Gerber MA, Thung SN, Shafritz DA.
    Cancer Res; 1981 Apr 07; 41(4):1342-50. PubMed ID: 6260336
    [Abstract] [Full Text] [Related]

  • 28. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH.
    Korean J Hepatol; 2008 Mar 07; 14(1):67-76. PubMed ID: 18367859
    [Abstract] [Full Text] [Related]

  • 29. Integration of hepatitis B virus DNA into cells of six established human hepatocellular carcinoma cell lines.
    Fujise K, Nagamori S, Hasumura S, Homma S, Sujino H, Matsuura T, Shimizu K, Niiya M, Kameda H, Fujita K.
    Hepatogastroenterology; 1990 Oct 07; 37(5):457-60. PubMed ID: 1701409
    [Abstract] [Full Text] [Related]

  • 30. Full-length genomic analysis of hepatitis B virus isolates in a patient progressing from hepatitis to hepatocellular carcinoma.
    Lin X, Qian GS, Lu PX, Wu L, Wen YM.
    J Med Virol; 2001 Jul 07; 64(3):299-304. PubMed ID: 11424118
    [Abstract] [Full Text] [Related]

  • 31. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH, Hung CH, Lee CM, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS.
    Gastroenterology; 2007 Nov 07; 133(5):1466-74. PubMed ID: 17915220
    [Abstract] [Full Text] [Related]

  • 32. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
    Dohmen K, Shigematsu H, Irie K, Ishibashi H.
    Hepatogastroenterology; 2003 Nov 07; 50(54):2022-7. PubMed ID: 14696457
    [Abstract] [Full Text] [Related]

  • 33. [Hepatitis B--a viral oncogene?].
    Weis NM, Krogsgaard K.
    Ugeskr Laeger; 2002 Dec 09; 164(50):5940-4. PubMed ID: 12553116
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
    Mwangi J, Gatei DG.
    East Afr Med J; 1993 Apr 09; 70(4 Suppl):34-6. PubMed ID: 8223308
    [Abstract] [Full Text] [Related]

  • 36. A study of alpha-fetoprotein in primary liver cancer in Tanzania.
    Spencer SS, Lindqvist KJ, Nantulya VM.
    East Afr Med J; 1991 Aug 09; 68(8):595-600. PubMed ID: 1722452
    [Abstract] [Full Text] [Related]

  • 37. A serological case-control study of primary hepatocellular carcinoma in Guangxi, China.
    Yeh FS, Mo CC, Luo S, Henderson BE, Tong MJ, Yu MC.
    Cancer Res; 1985 Feb 09; 45(2):872-3. PubMed ID: 2981615
    [Abstract] [Full Text] [Related]

  • 38. [Relation between serum markers of hepatitis B virus and alpha fetoprotein in hepatocellular carcinoma in France].
    Attali P, Prod'homme S, Pelletier G, Papoz L, Buffet C, Etienne JP.
    Gastroenterol Clin Biol; 1986 Oct 09; 10(10):637-40. PubMed ID: 2431948
    [Abstract] [Full Text] [Related]

  • 39. Hepatocellular carcinoma in hepatitis B surface antigen carriers in eight institutions.
    Lohiya GS, Pirkle H, Nguyen H, Lohiya S, Vuu T.
    West J Med; 1988 Apr 09; 148(4):426-9. PubMed ID: 2838975
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.